Boeing vs. Lockheed Martin: Which Essential U.S. Aerospace Stock Is a Better Buy in 2026?
Source: Nasdaq

Lockheed Martin is presented as the stronger 2026 value choice, trading at 17.3x forward earnings and 1.6x sales versus Boeing at 49.7x and 1.7x, respectively. Lockheed generated about $75.1B of FY2025 revenue (+6%), $5B-plus of net income and $6.9B of free cash flow, supported by long-duration F-35 demand, while sales are forecast to reach $79.1B this fiscal year. Boeing's FY2025 revenue rose 35% to approximately $89.5B and net income recovered to $2.2B, but negative $1.9B free cash flow, 10.0x debt-to-equity, FAA constraints, production delays and an expected decline in 2026 net income to roughly $85M leave its turnaround materially riskier.
Analysis
The relevant valuation distinction is not simply growth versus stability: BA remains an execution-duration asset, while LMT converts backlog into distributable cash. BA's equity value is highly sensitive to each incremental production-rate approval because fixed-cost absorption can create substantial operating leverage; however, its capital structure means an adverse certification, supplier-quality, or labor event has asymmetric downside through additional cash burn and delayed deleveraging. LMT's lower earnings multiple is more defensible only if its cash conversion persists; a continuing-resolution or delayed appropriations cycle can defer awards without necessarily impairing its multi-year earnings power.
A less obvious beneficiary of a protracted BA recovery is AIR rather than BA itself. Airbus can sustain pricing discipline and favorable delivery slots while airline customers lacking near-term Boeing capacity retain limited alternatives; GE Aerospace and RTX also have relatively cleaner exposure to the commercial aftermarket cycle than to BA's airframe execution risk. Conversely, SPR's economics may remain pressured during integration: resolving BA's quality bottleneck can require investment and concession costs before any consolidated margin benefit becomes visible.
Over the next 1-3 months, the key divergence catalyst is evidence that BA can convert deliveries into positive free cash flow without working-capital assistance, versus LMT's award cadence and FY guidance durability. Over 6-18 months, BA can outperform sharply if production normalization produces a credible cash-inflection and debt reduction path, but that outcome is not adequately captured by revenue growth alone. The contrarian risk for LMT is that investors are treating defense spending as homogeneous: F-35 sustainment, munitions, missile defense, and classified-space budgets can rotate materially among LMT, NOC, RTX, and GD even in an expanding defense budget.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
Key Decisions for Investors
- Initiate a 6-12 month long LMT / short BA dollar-neutral pair. The trade isolates cash-generative defense exposure from BA's certification and balance-sheet risk; target 15-20% relative outperformance, with a stop if BA demonstrates two consecutive quarters of positive free cash flow and raises production or cash guidance.
- Prefer long RTX or GE Aerospace exposure to a commercial-aerospace recovery over outright BA for the next 3-6 months. Aftermarket and engine-service revenue should monetize fleet utilization with less direct exposure to airframe delivery disruptions; reassess if airline capacity reductions or shop-visit deferrals emerge.
- Keep BA as a conditional upside watch rather than a core long: enter only following independently verifiable production-rate normalization plus positive quarterly free cash flow. A 12-18 month call-spread structure is preferable to common equity until net-debt reduction is visible; the missing underwriting data are program-level cash advances, supplier concessions, and the FAA production-rate path.
- Avoid treating SPR as a clean BA-synergy proxy until integration disclosures quantify quality-remediation costs, customer-contract liabilities, and standalone cash needs. A widening discount of SPR versus BA after those disclosures would be a potential long setup; absent that visibility, integration risk remains one-sided.
More News
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- Trump-Xi summit: Here’s what’s on the agenda, and why it matters
- Nscale wants a $35 billion valuation. Nvidia is helping foot the bill
- Why Fervo Energy Stock Is Up Today
- What must happen for Boeing stock to get unstuck. The company needs, at least, to do its part
- China vs US: Who is winning the AI race, in four charts
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More
- AI Software for Buy-Side Teams: Build the Research Stack